Pharmacokinetic Study Comparing Tiotropium Easyhaler® and Spiriva® HandiHaler®
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Healthy Volunteers
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: The study is a 2-part 4-period crossover study where the study subjects participate either in part 1 (20 subjects) or in part 2 (20 subjects). Parts can run in sequence or parallel. All study subjects receive single dose of Tiotropium Easyhaler on 3 periods and Spiriva HandiHaler on 1 period.Masking: None (Open Label)Masking Description: Bioanalytical laboratory will be blinded with regard to the sequence of the product administration.Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 60 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04850144
- Collaborators
- Not Provided
- Investigators
- Study Director: Orion Corporation Clinical Study Director Orion Corporation, Orion Pharma
Get Well Soon